UPC_CoA_93/2026
- Siemens Healthineers AG
- Siemens Healthineers Nederland B.V.
- Siemens Healthcare SAS
- Siemens Healthcare GmbH
- Hologic, Inc.
- Hologic, Inc., Marlborough, United States of America
Track this case
Get an email when a new order or decision is published in UPC_CoA_93/2026.
Decisions and documents (1)
- 2026-07-15procedural
- Applicants:
- Siemens Healthcare GmbH; Siemens Healthcare SAS; Siemens Healthineers AG; Siemens Healthineers Nederland B.V.
- Respondent:
- Hologic, Inc.
dismissed
The principle of the right to be heard according to Art. 76(2) UPCA obliges the court to take note of and give due consideration to the submissions of the parties to the proceedings. Among other things, this principle requires the court to deal with the essential substance of a party’s submissions and, insofar as they relate to a central issue in the proceedings in question, to address them in its reasoning. An infringement of this duty must be presumed if the grounds for the court’s decision allow only the conclusion that the court has completely disregarded the party’s submissions, or if the grounds are based on an interpretation that captures, at most, the literal wording but not the meaning of the party’s submissions. The right to be heard does not require the court to expressly and exhaustively address each and every argument in detail in its decision. At least the parties’ core arguments must be reflected in it.
Judge: Ulrike Voß • Panel: Nathalie Sabotier, Ulrike Voß
Weekly digest
A weekly email summarising new published decisions across European patent courts.